AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16210047
Drug: Tacrolimus (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus (0.1 mg/kg weight)
Trial: 10695777
Drug: artesunate (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: artesunate (total dose of 12 mg/kg over five days)
Trial: 19813462
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (alendronate 70 mg tablets)
Trial: 1725151
Drug: Cefixime 8
RxNorm normalized name: cefixime 8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 8 mg/kg once daily at bedtime for 10 days
Trial: 1725151
Drug: Amoxicillin 50
RxNorm normalized name: amoxicillin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 50 mg/kg/day in 3 divided doses for 10 days
Trial: 1906097
Drug: Cefixime and
RxNorm normalized name: cefixime and ornidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime and Amoxicillin
Trial: 30083110
Drug: Cinemotion training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinemotion training (delivered in weekly group sessions)
Trial: 29282952
Drug: Needle knife
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle knife therapy combined with rotation traction manipulation
Trial: 20473733
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine comprehensive therapy
Trial: 20473733
Drug: Chemotherapeutic agents
RxNorm normalized name: Other chemotherapeutics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapeutic agents with iodized oil chemo-embolization and analgesics
Trial: 16202258
Drug: Oral Leflunomide
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Leflunomide (LEF)
Trial: 8966308
Drug: Pentamidine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentamidine 4 mg/kg/every 2 days for 8 applications
Trial: 1898891
Drug: Low-dose follicle-stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose follicle-stimulating hormone (FSH)
Trial: 29558967
Drug: Juanbi pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juanbi pill
Trial: 24768543
Drug: Topical Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Tranexamic Acid (2.0g)
Trial: 24768543
Drug: Intravenous Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Tranexamic Acid (10mg/kg)
Trial: 24768543
Drug: Topical Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Tranexamic Acid
Trial: 20051288
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulphate 600 mg/day
Trial: 8471679
Drug: Oxaprotiline (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaprotiline (a highly specific inhibitor of NA uptake)
Trial: 6361788
Drug: Suprofen 200
RxNorm normalized name: suprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprofen 200 mg
Trial: 3896016
Drug: Cosalgesic (dextropropoxyphene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cosalgesic (dextropropoxyphene hydrochloride 65 mg and paracetamol 650 mg)
Trial: 29739384
Drug: Group Cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive Behavioural Therapy (CBT) intervention plus Treatment as Usual (TAU)
Trial: 24916165
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (50 mg Fe as FeSO₄, 4 days/week for 38 weeks)
Trial: 15531007
Drug: Duloxetine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 120 mg/d
Trial: 11879862
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day enalapril for 2 years
Trial: 3541062
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (controls)
Trial: 10439732
Drug: Rapacuronium 1
RxNorm normalized name: rapacuronium 100 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapacuronium 1 mg/kg
Trial: 10439732
Drug: Rapacuronium 2
RxNorm normalized name: rapacuronium 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapacuronium 2 mg/kg
Trial: 10439732
Drug: Rapacuronium 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapacuronium 3 mg/kg
Trial: 8537687
Drug: 23-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae type 1 capsular polysaccharide antigen
DrugBank: Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent pneumococcal polysaccharide vaccine
Trial: 323297
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium phosphate (80 mg, multiple doses)
Trial: 29205786
Drug: Semaglutide 0.5
RxNorm normalized name: semaglutide 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide 0.5 mg subcutaneous dose
Trial: 27521353
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) for 2 weeks
Trial: 2068469
Drug: Aztreonam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aztreonam (1 g intravenously 30 minutes before surgery and 8 and 16 hours after surgery)
Trial: 2068469
Drug: Gentamicin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (80 mg intravenously 30 minutes before surgery and 8 and 16 hours after surgery)
Trial: 30888478
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg daily for 6 months
Trial: 22475593
Drug: Pyronaridine-artesunate (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyronaridine-artesunate (180 mg pyronaridine and 60 mg artesunate, administered once daily for 3 days)
Trial: 22475593
Drug: Mefloquine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine plus artesunate (250 mg mefloquine and 100 mg artesunate, administered once daily for 3 days)
Trial: 20813564
Drug: 25% podophyllin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% podophyllin resin with 1% penciclovir cream (PP)
Trial: 16258087
Drug: Tamoxifen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (30 mg daily for 5 years)
Trial: 1954079
Drug: Frusemide 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide 40 mg
Trial: 8172095
Drug: 1,25-dihydroxyvitamin D
RxNorm normalized name: 1,25-dihydroxyvitamin D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxyvitamin D (1,25(OH)2D) treatment (1 micrograms/d for 4 d)
Trial: 3351700
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg intravenous metoclopramide
Trial: 31436322
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (nCT) with cisplatin 100 mg/m2 on day 1 and 750 mg/m2 5-fluorouracil over 24 hours on days 1-5 for three 21-day cycles
Trial: 23171567
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT), n = 60, energy dose of 6 J per tender point, treated three times per week for four weeks (total of 12 sessions).
Trial: 23171567
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT), n = 60.
Trial: 17397005
Drug: Loop electrosurgical
RxNorm normalized name: LOOP OSTOMY ROD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop electrosurgical excision procedure (LEEP) for CIN3 treatment
Trial: 15105817
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intravitreal injection)
Trial: 12498843
Drug: Heparin-surface-modified PMMA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-surface-modified PMMA (HSM PMMA) IOL
Trial: 9834303
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and warfarin
Trial: 8014643
Drug: Miller Galante
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Miller Galante I (MG I)
Trial: 6777458
Drug: Clovoxamine 50
RxNorm normalized name: fluvoxamine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clovoxamine 50 mg
Trial: 29363217
Drug: Imipramine 75
RxNorm normalized name: trimipramine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 75 mg
Trial: 31813228
Drug: Lay counselor-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lay counselor-delivered problem-solving therapy
Trial: 23588864
Drug: Tramadol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (200 mg added to treatment)
Trial: 23588864
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl (TDF) (initial dose of 25 µg/h, increased by 25 µg/h as needed)
Trial: 19065670
Drug: Adefovir 10
RxNorm normalized name: adefovir 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 10 mg/day
Trial: 17006279
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza vaccine, trivalent (CAIV-T)
Trial: 7493436
Drug: Octreotide (subcutaneous)
DrugBank: Octreotide (DB00104)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Octreotide (subcutaneous)
Trial: 2966565
Drug: Sequential intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential intravenous streptokinase and PTCA
Trial: 2966565
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase with angioplasty
Trial: 30777027
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia (PCIA)
Trial: 18710603
Drug: Sex, BMI,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex, BMI, contraceptive pill use (as variables)
Trial: 8951977
Drug: Caffeine (3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3.3 mg/kg, equivalent to 2‐3 cups of coffee)
Trial: 1849730
Drug: Oral pyridostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pyridostigmine 30 mg 8 hourly
Trial: 28760403
Drug: Immediate androgen-deprivation
RxNorm normalized name: hydrogen peroxide Topical Solution [IR DIP 10]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate androgen-deprivation therapy
Trial: 28760403
Drug: Delayed androgen-deprivation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed androgen-deprivation therapy
Trial: 22282548
Drug: Palovarotene 5
RxNorm normalized name: palovarotene 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palovarotene 5 mg·day(‐1) for 1 year
Trial: 18385594
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous naloxone
Trial: 26683986
Drug: Lactotripeptides (10.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactotripeptides (10.2 mg/day)
Trial: 11753137
Drug: Empiric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric treatment for interstitial cystitis; specific treatments not detailed.
Trial: 1574973
Drug: Methohexitone infusion
RxNorm normalized name: Methohexitone
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methohexitone infusion
Trial: 3893488
Drug: Sotalol 1
RxNorm normalized name: sotalol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 1 mg/kg bolus intravenously plus 0.2 mg/kg intravenously over 12 hours
Trial: 3893488
Drug: Digoxin 0.75
RxNorm normalized name: digoxin 0.75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.75 mg intravenously, then disopyramide 2 mg/kg intravenous bolus and 0.4 mg/kg/h intravenously for 10 hours
Trial: 11108307
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (including placebo)
Trial: 29031409
Drug: 15-20 mg
RxNorm normalized name: SALICYLIC ACID 15% 20MM PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-20 mg DSP (Group 1A)
Trial: 29031409
Drug: 2.5-5 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5-5 mg DSP (Group 1B)
Trial: 29031409
Drug: 15-20 mg
RxNorm normalized name: SALICYLIC ACID 15% 20MM PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-20 mg DSP (Group 2B)
Trial: 23816952
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 9% CO2
Trial: 23816952
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 0% CO2
Trial: 20584994
Drug: Interaction effect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interaction effect of genotype and CO2 dosage
Trial: 18175148
Drug: IVMP (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVMP (intravenous methylprednisolone pulse), 30 mg/kg/day for 3 days
Trial: 8200169
Drug: Cefoperazone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone plus IVIG (500 mg/kg on days 1, 2, 3, and 8)
Trial: 24750839
Drug: Hormone treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone treatment with dexamethasone 0.25‐0.3 mg/(kg·d) followed by oral prednisone tablets 0.5‐1 mg/(kg·d) for 7‐10 days
Trial: 24750839
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment with azithromycin and symptomatic therapies
Trial: 20801122
Drug: Linaclotide 75
RxNorm normalized name: Linaclotide
DrugBank: Linaclotide (DB08890)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linaclotide 75 μg
Trial: 20801122
Drug: Linaclotide 150
RxNorm normalized name: Linaclotide
DrugBank: Linaclotide (DB08890)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linaclotide 150 μg
Trial: 20801122
Drug: Linaclotide (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide (all doses)
Trial: 31060836
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FOG) - 1.55 g of EPA + DHA per day for nine weeks
Trial: 31060836
Drug: Placebo (PG)
RxNorm normalized name: PG-530742
DrugBank: PG-530742 (DB05495)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PG) - Olive oil capsules
Trial: 21030368
Drug: Formoterol (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol (36 μg)
Trial: 10195674
Drug: Pertussis vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pertussis vaccine
Trial: 2209411
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine (8 mg) daily for 18 days, then daily or alternate days from day 19-36
Trial: 31067546
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium bicarbonate supplementation to achieve serum HCO3- levels of 24 ± 1 mmol/L
Trial: 23746749
Drug: Lower dentures
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dentures supported by implants
Trial: 21193975
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine first
Trial: 21193975
Drug: Hepatitis‐B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis‐B vaccine first
Trial: 16840383
Drug: 0.5 mg/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg/d prednisone for 14 days
Trial: 9375818
Drug: Pulse oral
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse oral calcitriol
Trial: 7552095
Drug: Intravenous calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous calcitriol
Trial: 3908009
Drug: Co-trimoxazole (single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (single-dose preoperative)
Trial: 25133963
Drug: etoricoxib 30
RxNorm normalized name: Etoricoxib 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib 30 mg (qd)
Trial: 22394170
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of EPA-DHA (n = 453)
Trial: 17344513
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg/d for 14 days)
Trial: 2183942
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg daily after RT)
Trial: 7426142
Drug: Propranolol 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 0.1 mg/kg intravenously followed by 320 mg in divided doses over 27 hours orally
Trial: 10448260
Drug: Glycyl‐L‐glutamine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyl‐L‐glutamine supplementation
Trial: 26070531
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy
Trial: 18588736
Drug: Observation without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Observation without therapy
Trial: 21617973
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (Laser Smile™, Biolase®, San Clemente, USA) applied to the wound after surgery with 5 J/cm² energy density, 810 nm wavelength, and 0.5 W output power.
Trial: 10084567
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg isoflavones from red clover
Trial: 10084567
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg isoflavones from red clover
Trial: 25466315
Drug: Humalog insulin
RxNorm normalized name: insulin lispro Cartridge [Humalog]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Humalog insulin (Hlog)
Trial: 30968588
Drug: Oral palonosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral palonosetron 0.50 mg
Trial: 21034692
Drug: Levetiracetam (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (up to 2,500 mg/d flexibly dosed)
Trial: 14979621
Drug: Doxazosin as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin as add-on therapy
Trial: 11337538
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg oral amphetamine
Trial: 9398701
Drug: GH and
RxNorm normalized name: Cough And Cold
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH and LH‐releasing hormone (LHRH) analog
Trial: 7956639
Drug: Nicotinamide (NCT)
DrugBank: Nicotinamide (DB02701)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinamide (NCT) plus deflazacort (DFL) for 3 months (25 mg.kg-1.day-1 for NCT, 0.6 mg.kg-1.day-1 for DFL in the first month, 0.3 mg.kg-1.day-1 for DFL in the other 2 months)
Trial: 3316240
Drug: Cefuroxime administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime administered at various intervals before tourniquet inflation
Trial: 30784669
Drug: Low post-PCI
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low post-PCI bivalirudin infusion (0.25 mg/kg/h for ≤6 h)
Trial: 30784669
Drug: No post-PCI
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No post-PCI bivalirudin infusion or heparin
Trial: 25197733
Drug: Chocobar ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chocobar ice cream without probiotics
Trial: 15262457
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg
Trial: 15262457
Drug: Dimenhydrinate 40
RxNorm normalized name: dimenhydrinate 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimenhydrinate 40 mg
Trial: 8483109
Drug: Zidovudine, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine, 200 mg orally every 4 hours (1,200 mg daily)
Trial: 27518195
Drug: 8-mg/h continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-mg/h continuous intravenous infusion of omeprazole (OME) for 72 hours
Trial: 27518195
Drug: 40-mg intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-mg intravenous omeprazole (OME) bolus injection every 12 hours
Trial: 2076713
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg daily)
Trial: 20042452
Drug: Seawater gel
RxNorm normalized name: Sodium Chloride 2600 mg in 100 mL NASAL SPRAY [NasalAsalt All-Natural Seawater]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seawater gel nasal spray for 10 days
Trial: 16415377
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atorvastatin per day